Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Cancers|July 24, 2021
Polyester Polymeric Nanoparticles as Platforms in the Development of Novel Nanomedicines for Cancer TreatmentEnrique Niza, Alberto Ocaña, José Antonio Castro-Osma, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 12, 2025
Nanotechnology-based approaches for head and neck cancer treatmentAlmudena Del Campo-Balguerías, Corina Lorz, Alberto Ocaña, et al.
International Journal of Molecular Sciences|August 23, 2020
Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer TreatmentAlberto Juan, Francisco J Cimas, Iván Bravo, et al.
Pharmaceutics|August 29, 2020
An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer TherapyAlberto Juan, Francisco J Cimas, Iván Bravo, et al.
Frontiers in Cell and Developmental Biology|February 21, 2022
Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery NanoparticlesAlberto Juan, María Del Mar Noblejas-López, María Arenas-Moreira, et al.
Chempluschem|January 25, 2020
Toward the Prediction of Activity in the Ethylene Polymerisation of ansa-Bis(indenyl) Zirconocenes: Effect of the Stereochemistry and Hydrogenation of the Indenyl MoietyIván Bravo, Carlos Alonso-Moreno, Fernando Carrillo-Hermosilla, et al.
Polymers|July 19, 2021
The Effect of WS<sub>2</sub> Nanosheets on the Non-Isothermal Cold- and Melt-Crystallization Kinetics of Poly(l-lactic acid) NanocompositesMohammed Naffakh, Pablo Rica, Carmen Moya-Lopez, et al.
Dalton Transactions (Cambridge, England : 2003)|October 8, 2009
Synthesis and structures of complexes with axially chiral isoquinolinyl-naphtholate ligandsRuth H Howard, Carlos Alonso-Moreno, Lewis M Broomfield, et al.
Pharmaceutics|August 26, 2022
Polylactide Perspectives in Biomedicine: From Novel Synthesis to the Application PerformanceCarmen Moya-Lopez, Joaquín González-Fuentes, Iván Bravo, et al.
Journal of Inorganic Biochemistry|January 24, 2024
Evaluation of heteroscorpionate ligands as scaffolds for the generation of Ruthenium(II) metallodrugs in breast cancer therapyElena Domínguez-Jurado, Consuelo Ripoll, Agustín Lara-Sánchez, et al.
Pageof 8